Prognostic factors in patients with synchronous peritoneal carcinomatosis (PC) caused by a primary cancer of the colon

Journal of Gastrointestinal Surgery

Volumn 13, Issue 9, 2009, Pages 1593-1598

  Sadahiro, Sotaro ^a   Suzuki, Toshiyuki ^a   Maeda, Yuji ^a   Tanaka, Akira ^a   Makuuchi, Hiroyasu ^a   Kamijo, Akemi ^a   Haruki, Yasuo ^b   Murayama, Chieko ^b  

^a TOKAI UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colon cancer; Metastasis; Peritoneal carcinomatosis (PC); Prognostic factor

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER INVASION; CANCER STAGING; CARCINOMA; CHI SQUARE DISTRIBUTION; COLON RESECTION; COLON TUMOR; COMPARATIVE STUDY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LAPAROTOMY; LYMPH NODE METASTASIS; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIPLE CANCER; NONPARAMETRIC TEST; PATHOLOGY; PERITONEUM TUMOR; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; COLECTOMY; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LAPAROTOMY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PERITONEAL NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349420908     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-0939-y     Document Type: Article

References (23)

1. Jemal A, Siegel, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66. doi:10.3322/canjclin.57.1.43.
2. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-592. doi:10.1093/annonc/mdl498.
3. Galandiuk S, Wieand HS, Moetel CG, Cha SS, Fitzgibbons RJ Jr, Pemberton JH, Wolff BG. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 1992;174:27-32.
4. Tominaga T, Sakabe T, Koyama Y, Hamano K, Yasutomi M, Takahashi T et al. Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Five-year follow-up report. Cancer 1996;78:403-408. doi:10.1002/(SICI)1097-0142(19960801)78:3<403::AID-CNCR4>3.0.CO;2-K.
5. Sadahiro S, Suzuki T, Ishikawa K, Nakamura T, Tanaka Y, Masuda T et al. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepatogastroenterology 2003;50:1362-1366.
6. Brodsky JT, Cohen AM. Peritoneal seeding following potentially curative resection of colonic carcinoma: implication for adjuvant therapy. Dis Colon Rectum 1991;34:723-727. doi:10.1007/BF02050360.
7. Dawson LE, Russell AH, Tong D, Wisbeck WM. Adenocarcinoma of the sigmoid colon: sites of initial dissemination and clinical patterns of recurrence following surgery alone. J Surg Oncol 1983;22:95-99. doi:10.1002/jso.2930220208.
8. Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy: a prospective study of prognostic factors. Cancer 1989;63:364-367. doi:10.1002/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V.
9. Russell AH, Tong D, Dawson LE, Wisbeck W. Adenocarcinoma of the proximal colon, sites of initial dissemination and patterns of recurrence following surgery alone. Cancer 1984;53:360-367. doi:10.1002/1097-0142(19840115)53:2<360::AID-CNCR2820530232>3.0.CO;2-U.
10. Shepherd NA, Baxter KJ, Love SB. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterol 1997;112:1096-1102. doi:10.1016/S0016-5085(97)70119-7.
11. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J et al. Peritoneal carcinomatosis from non-gynecologic malignancies: result of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88:358-363. doi:10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O.
12. Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002;89:1545-1550. doi:10.1046/j.1365-2168.2002.02274.x.
13. Pelz JOW, Stojadinovic A, Nissan A, Hohenberger W, Esquivel J. Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis. J Surg Oncol 2009;99:9-15. doi:10.1002/jso.21169.
14. Verwaal VJ, van Ruth S, de Bree E, van Slooten GW, van Tinteren H, Boot H, Zoetmulder AN. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003;21:3737-3743. doi:10.1200/JCO.2003.04.187.
15. Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M et al. Cytoreductive surgery combined with perioperative intraperitoneal carcinomatosis from colorectal cancer: a multi-institution study. J Clin Oncol 2004;22:3284-3292. doi:10.1200/JCO.2004.10.012.
16. Hurwitz H, Fehrenbacher L, Novotny W, Carwright T, Hainsworth J, Heim W et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-2342. doi:10.1056/NEJMoa032691.
17. Grothey A, Sargent D, Goldberg RM, Schmoll HJ. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 2004;22:1209-1214. doi:10.1200/JCO.2004.11.037.
18. Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 1993;72:1631-1636. doi:10.1002/1097-0142(19930901)72:5<1631::AID-CNCR2820720523>3.0.CO;2-I.
19. Japanese Society for Cancer of the Colon and Rectum. General rules for clinical and pathological studies on cancer of colon, rectum and anus, 7th edn. Tokyo: Kanehara shuppan, 1997.
20. Verwaal VJ, van Tinteren H, van Ruth S, Zoetmulder AN. Predicting the survival of patients with peritoneal carcinomatosis of colorectal original treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg 2004;91:739-746. doi:10.1002/bjs.4516.
21. Gilly F, Beaujard A, Glehen O, Grandclement E, Caillot JL, Francois Y et al. Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study. Anticancer Res 1999;19:2317-2322.
22. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 1996;82:359-374.
23. Lambert LA, Mansfield PF. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal carcinomatosis: if at first you don't succeed.... Ann Surg Oncol 2007;14:3037-3039. doi:10.1245/s10434-007-9548-8.